BioRelix, Inc., a biopharmaceutical company, engages in the discovery and development of anti-biotic drug candidates for the treatment of infectious diseases in the United States. It develops a portfolio of riboswitch-based therapeutic agents to overcome the lethal and devastating causes of bacterial infections. The company was founded in 2005 and is based in New Haven, Connecticut.
Funding Rounds (7) - $40.7MUpdate
Board Members and Advisors (7)Update
Connecticut Innovations provides strategic capital and operational insight to to companies in...
OpGen focuses on commercializing solutions for DNA analysis and genomics with the Argus® whole...
Health-Care Focused VC Firm
Venture capital Firm
Alexandria Real Estate Equities, Inc., Landlord of Choice to the Life Science Industry, is the...
Aisling Capital believes the next decade will be marked by a revolution in healthcare driven by...
5 Science Park
401 Winchester Avenue
New Haven, CT 06511